Home LiteratureArticle Details
PMID: 19298652 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo.

BMC immunology ·Vol. 10 ·2009-03-19 ·Pages 14

Bonville CA, Percopo CM, Dyer KD, Gao J, Prussin C, Foster B, Rosenberg HF, Domachowske JB

Abstract

We have shown previously that acute infection with the respiratory pathogen, pneumonia virus of mice (PVM), results in local production of the proinflammatory chemokine, CCL3, and that neutrophil recruitment in response to PVM infection is reduced dramatically in CCL3 -/- mice. In this work, we demonstrate that CCL3-mediated neutrophil recruitment is coordinated by interferon-gamma (IFNgamma). Neutrophil recruitment in response to PVM infection was diminished five-fold in IFNgamma receptor gene-deleted mice, although neutrophils from IFNgammaR -/- mice expressed transcripts for the CCL3 receptor, CCR1 and responded functionally to CCL3 ex vivo. Similarly, in the absence of PVM infection, CCL3 overexpression alone could not elicit neutrophil recruitment in the absence of IFNgamma. Interestingly, although supplemental IFNgamma restored neutrophil recruitment and resulted in a sustained weight loss among CCL3-overexpressing IFNgamma -/- mice, CCL3-mediated neutrophil recruitment alone did not result in the pulmonary edema or respiratory failure characteristic of severe viral infection, suggesting that CCL3 and IFN-gamma together are sufficient to promote neutrophil recruitment but not pathologic activation. Our findings reveal a heretofore unrecognized hierarchical interaction between the IFNgamma and CCL3, which demonstrate that IFNgamma is crucial for CCL3-mediated neutrophil recruitment in vivo.

MeSH Terms
Animals Cell Movement/immunology Chemokine CCL3/genetics,immunology,metabolism Gene Expression Profiling Interferon-gamma/genetics,immunology,metabolism Killer Cells, Natural/immunology,metabolism,pathology Lung/immunology,metabolism,pathology,virology Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Knockout Murine pneumonia virus/immunology,pathogenicity Neutrophils/immunology,metabolism,pathology Pneumovirus Infections/genetics,immunology,physiopathology Pulmonary Edema Receptors, CCR1/genetics,immunology,metabolism Receptors, Interferon/genetics,immunology,metabolism Respiratory Insufficiency Signal Transduction/immunology T-Lymphocytes/immunology,metabolism,pathology
Chemicals
Chemokine CCL3 Receptors, CCR1 Receptors, Interferon interferon gamma receptor Interferon-gamma
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Bonville Cynthia A
SUNY Upstate Medical University, Syracuse, New York 13210, USA. [email protected]
Percopo Caroline M
Dyer Kimberly D
Gao Jiliang
Prussin Calman
Foster Barbara
Rosenberg Helene F
Domachowske Joseph B
References (55)
55 references, click to expand
  1. Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo.
    J Virol. 2004 Aug;78(15):7984-9 PMID: 15254170
  2. Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection.
    J Immunol. 2005 Nov 15;175(10):6597-604 PMID: 16272314
  3. Characteristics of the multiplication cycle of pneumonia virus of mice (PVM).
    J Exp Med. 1951 Feb;93(2):151-60 PMID: 14803639
  4. Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia.
    J Leukoc Biol. 2002 Sep;72(3):571-9 PMID: 12223526
  5. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1.
    J Exp Med. 1997 Jun 2;185(11):1959-68 PMID: 9166425
  6. Immunization strategies for the prevention of pneumovirus infections.
    Expert Rev Vaccines. 2007 Apr;6(2):169-82 PMID: 17408367
  7. Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains.
    Am J Physiol Lung Cell Mol Physiol. 2006 Sep;291(3):L426-35 PMID: 16556725
  8. Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro.
    J Virol. 2006 Mar;80(6):2684-93 PMID: 16501078
  9. Bronchoalveolar lavage fluids of ventilated patients with acute lung injury activate NF-kappaB in alveolar epithelial cell line: role of reactive oxygen/nitrogen species and cytokines.
    Nitric Oxide. 2003 Aug;9(1):33-43 PMID: 14559430
  10. Immune response in mice that lack the interferon-gamma receptor.
    Science. 1993 Mar 19;259(5102):1742-5 PMID: 8456301
  11. Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data.
    Clin Infect Dis. 2006 Sep 15;43(6):748-56 PMID: 16912951
  12. The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection.
    J Immunol. 2000 Sep 1;165(5):2677-82 PMID: 10946298
  13. Role for innate IFNs in determining respiratory syncytial virus immunopathology.
    J Immunol. 2005 Jun 1;174(11):7234-41 PMID: 15905569
  14. Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis.
    Virology. 2006 May 25;349(1):87-95 PMID: 16563455
  15. Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants.
    Pediatrics. 2007 Aug;120(2):e410-5 PMID: 17671045
  16. Respiratory syncytial virus-induced immunoprotection and immunopathology.
    Viral Immunol. 2004;17(3):370-80 PMID: 15357903
  17. An interferon-gamma-related cytokine storm in SARS patients.
    J Med Virol. 2005 Feb;75(2):185-94 PMID: 15602737
  18. Natural inhibitors of neutrophil function in acute respiratory distress syndrome.
    Crit Care Med. 2001 Oct;29(10):1920-4 PMID: 11588452
  19. Early alterations in neutrophil activation are associated with outcome in acute lung injury.
    Am J Respir Crit Care Med. 2003 Jun 1;167(11):1567-74 PMID: 12626346
  20. The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention.
    Pharmacol Ther. 2005 Jan;105(1):1-6 PMID: 15626452
  21. Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P.
    PLoS One. 2007 Oct 17;2(10):e1038 PMID: 17940602
  22. Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection.
    J Infect Dis. 2007 Jun 15;195(12):1779-88 PMID: 17492594
  23. Interferon-gamma activation of polymorphonuclear neutrophil function.
    Immunology. 2004 May;112(1):2-12 PMID: 15096178
  24. Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice.
    Vaccine. 2007 Jan 22;25(6):1085-95 PMID: 17052820
  25. Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses.
    J Infect Dis. 2006 Jul 1;194(1):61-70 PMID: 16741883
  26. Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease.
    Am J Respir Crit Care Med. 1999 Oct;160(4):1263-8 PMID: 10508817
  27. Reduced interferon-gamma production in infants with bronchiolitis and asthma.
    Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1417-22 PMID: 10228104
  28. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome.
    J Chin Med Assoc. 2005 Jan;68(1):4-10 PMID: 15742856
  29. Role of T cells in virus control and disease after infection with pneumonia virus of mice.
    J Virol. 2008 Dec;82(23):11619-27 PMID: 18815308
  30. Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin.
    Science. 1965 Jul 16;149(3681):310-1 PMID: 17838106
  31. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis.
    Am J Respir Crit Care Med. 2003 Sep 15;168(6):633-9 PMID: 12773328
  32. Characterization of the interaction between recombinant human interferon-gamma and its receptor on human polymorphonuclear leukocytes.
    J Leukoc Biol. 1990 Jan;47(1):64-9 PMID: 2136748
  33. Acute respiratory distress syndrome caused by respiratory syncytial virus.
    Pediatr Pulmonol. 1997 Mar;23(3):176-83 PMID: 9094725
  34. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection.
    J Exp Med. 2006 Jul 10;203(7):1805-15 PMID: 16818672
  35. Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modulating neutrophil recruitment.
    Pancreas. 2007 Mar;34(2):233-41 PMID: 17312463
  36. Requirement of MIP-1 alpha for an inflammatory response to viral infection.
    Science. 1995 Sep 15;269(5230):1583-5 PMID: 7667639
  37. Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release.
    J Surg Res. 1998 Apr;76(1):91-4 PMID: 9695746
  38. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.
    Antimicrob Agents Chemother. 2004 May;48(5):1811-22 PMID: 15105140
  39. Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity.
    J Infect Dis. 2001 Aug 1;184(3):355-8 PMID: 11443563
  40. Pneumonia virus of mice: severe respiratory infection in a natural host.
    Immunol Lett. 2008 Jun 15;118(1):6-12 PMID: 18471897
  41. Pathology of fatal human infection associated with avian influenza A H5N1 virus.
    J Med Virol. 2001 Mar;63(3):242-6 PMID: 11170064
  42. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis.
    J Infect Dis. 2005 Apr 15;191(8):1225-32 PMID: 15776367
  43. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice.
    Am J Respir Crit Care Med. 2006 Nov 1;174(9):1011-7 PMID: 16917113
  44. IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus.
    Am J Respir Crit Care Med. 2008 Jan 15;177(2):208-18 PMID: 17962634
  45. Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents.
    J Virol. 2003 Jan;77(2):1237-44 PMID: 12502841
  46. ARDS in SARS: cytokine mediators and treatment implications.
    Cytokine. 2005 Jan 21;29(2):92-4 PMID: 15598444
  47. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection.
    J Immunol. 2000 Dec 1;165(11):6429-36 PMID: 11086082
  48. Inflammatory profile in nasal secretions of infants hospitalized with acute lower airway tract infections.
    Respirology. 2005 Jun;10(3):365-70 PMID: 15955151
  49. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils.
    J Immunol. 1999 Jan 1;162(1):474-9 PMID: 9886422
  50. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
    Science. 1993 Mar 19;259(5102):1739-42 PMID: 8456300
  51. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice.
    J Immunol. 2004 Sep 15;173(6):4030-9 PMID: 15356152
  52. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.
    J Virol. 2007 Mar;81(6):2736-44 PMID: 17182684
  53. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation.
    Am J Respir Crit Care Med. 1999 Jun;159(6):1918-24 PMID: 10351940
  54. F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor.
    J Immunol. 2007 Feb 1;178(3):1450-6 PMID: 17237393
  55. Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection.
    Expert Rev Anti Infect Ther. 2007 Jun;5(3):415-25 PMID: 17547506
Article Info
Journal
BMC immunology
Abbr.
BMC Immunol
ISSN
1471-2172
Published
2009-03-19
Epub
2009-00-19
Pages
14
Language
English
Region
England
NLM ID
100966980
PMCID
PMC2662797
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]